Medical Communications

On the day that news broke, through Pulse, that over a million patients have had to move GP surgery in …

It’s a special Firday here in Europe, as today marks the advent of the General Data Protection Regulation (GDPR), an …

BioMarin is confident that its newly approved treatment for phenylketonuria (PKU) is set to become a blockbuster and it’s priced the …

AstraZeneca and its global biologics R&D MedImmune have lifted the curtain on new Phase 3 data for their immunotherapy Imfinzi …

The news broke at the start of the month that a number of women who should have been invited to …

Prothena Therapeutics has acted drastically by slashing staff numbers by more than half, after the failure of two pivotal trials …

Pharmafocus spoke to John Crowley, CEO of Amicus Therapeutics, about his highly unusual career in the pharmaceutical and biotech industries.

Astellas, under the direction of new CEO, Kenji Yasukawa, has unveiled a major new restructure, ahead of a difficult looking …

A report published by the Institute for Fiscal Studies (IFS) has stressed that UK funding into the NHS needs to …

The Royal Liverpool and Broadgreen University Hospitals NHS Trust has teamed up with a provider of AI systems to introduce …

Gene Matthews, Partner at Leigh Day, reviews the tough decisions the UK has to make regarding its position in the …

The year is flying by – it’s another Friday, and that means another Top Ten run-down.Perhaps the biggest story this …

The Ebola outbreak in the Democratic Republic of Congo is becoming increasingly serious, after it was confirmed that there was …

Pfizer has revealed new Phase 3 data for its oral epilepsy therapy Lyrica (pregbalin) as an adjunctive treatment for partial …

The first in a new class of migraine treatments has just received approval from the FDA; Amgen and Novartis’ Aimovig …